Our Firm

News

Newstrike Completes Previously Announced $80 Million Bought Deal Financing

TORONTO, Feb. 16, 2018 (GLOBE NEWSWIRE) — Newstrike Resources Ltd. (TSXV:HIP(“Newstrike” or the “Company”) is pleased to announce that it has closed its previously announced short form prospectus offering on a bought deal basis.  A total of 60,610,000 units of the Company (“Units”) were sold at a price of $1.32 per Unit (the “Issue Price”), for aggregate gross proceeds of $80,005,200 (the “Offering”).  The Offering was underwritten by a syndicate of underwriters co-led by INFOR Financial Inc. and Cormark Securities Inc. and including Eight Capital and Haywood Securities Inc. (collectively, the “Underwriters”).

Click here to continue reading the article

Scythian Biosciences Announces Closing of $28.7 Million Financing with Aphria Inc. as Lead Investor

TORONTO, Feb. 13, 2018 (GLOBE NEWSWIRE) — Scythian Biosciences Corp. (the “Company” or “Scythian”) (TSXV:SCYB) (Frankfurt:9SB) (OTCQB:SCCYF) is pleased to announce that it has today closed its previously announced “bought deal” short form prospectus offering, including the full exercise of the over-allotment option (the “Offering”).

Click here to continue reading the article

Newstrike Resources Ltd. Announces Upsize of Previously Announced Bought Deal Financing to $80 million

Newstrike Resources Ltd. (TSX VENTURE:HIP) (“Newstrike” or the “Company”) is pleased to announce that the Company has entered into a revised agreement with a syndicate of underwriters co-led by INFOR Financial Inc. and Cormark Securities Inc. (collectively, the “Underwriters”), to increase the size of its previously announced bought deal financing to $80,005,200 aggregate gross proceeds (the “Offering”), representing 60,610,000 Units of the Company (the “Units”), at a price of $1.32 per Unit (the “Issue Price”).

Click here to continue reading the article

Newstrike Resources Ltd. Announces $50 Million Bought Deal Financing

Newstrike Resources Ltd. (TSX VENTURE:HIP) (“Newstrike” or the “Company”) is pleased to announce that it has entered into an agreement with a syndicate of underwriters (the “Underwriters”) co-led by INFOR Financial Inc. and Cormark Securities Inc. pursuant to which the Underwriters have agreed to purchase 39,000,000 units (the “Units”) of the Company on a “bought deal” basis pursuant to a short form prospectus to be filed, subject to all required regulatory approvals, at a price per Unit of $1.32 (the “Issue Price”) for gross proceeds of $51,480,000 (the “Offering”).

Click here to continue reading the article

Axis Closes Previously Announced Financing with Total Gross Proceeds of $19M

TORONTOJan. 19, 2018 /CNW/ – Axis Auto Finance Inc. (TSXV:AXIS) (“Axis” or “the Company”), is pleased to announce that it has completed its previously announced marketed financing (the “Offering”). Pursuant to the Offering, Axis issued a total of 27,142,858 subscription receipts (“Subscription Receipts”) at a price of $0.70 per Subscription Receipt for gross proceeds of approximately $19 million. The syndicate of agents was co-led by Canaccord Genuity Corp. and INFOR Financial Inc. and included PI Financial Corporation and Raymond James Ltd.

Click here to continue reading the article

Axis Auto Finance Announces Upsize of Previously Announced Financing

TORONTOJan. 17, 2018 /CNW/ – Axis Auto Finance Inc. (TSXV:AXIS) (“Axis” or “the Company”), is pleased to announce today that it has entered into an amended agreement with Canaccord Genuity Corp. and INFOR Financial Inc. (as “Co-Lead Agents”) and including PI Financial Corporation and Raymond James Ltd. (collectively, the “Agents”), to increase the size of the previously announced offering of subscription receipts (the “Subscription Receipts”) of the Company. Under the amended terms of the offering, Axis has agreed to sell an additional 7,285,714 Subscription Receipts, on a private placement basis at a price of $0.70 per Subscription Receipts, for a total of 25,714,285 Subscription Receipts issued under the Offering for total gross proceeds of $18 million (the “Offering”). In addition, the Agents have been granted an option, exercisable in whole or in part at the offer price not later than closing of the Offering, to purchase up to 3,085,714 Subscription Receipts for additional gross proceeds of $2.16 million.

Click here to continue reading the article

Scythian Biosciences Announces Aphria as Lead Investor in $20 Million Financing

Scythian Biosciences Corp. (the “Company” or “Scythian“) (TSX VENTURE:SCYB)(FRANKFURT:9SB)(OTCQB:SCCYF) is pleased to announce that it has today entered into an agreement with a syndicate of underwriters led by Clarus Securities Inc. (the “Underwriters“), pursuant to which the Underwriters have agreed to purchase, on a bought deal basis, up to 537,700 units (the “Units“) of the Company at a price of C$18.60 per Unit (the “Offering Price“) for gross proceeds of C$10,001,220. Each Unit will be comprised of one common share of the Company (a “Unit Share“) and one common share purchase warrant (a “Warrant“). Each Warrant will entitle the holder thereof to purchase one common share of the Company at a price of C$22.00 for a period of 24 months following the Closing Date (as defined below).

Click here to continue reading the article

Sangoma Announces Sixth Acquisition In Six Years Buying All Key Assets of CCD Division from Dialogic Corporation

MARKHAM, Ontario, Jan. 9, 2018 /PRNewswire/ — Sangoma Technologies Corporation (TSX VENTURE: STC), a trusted leader in delivering Unified Communications solutions for SMBs, Enterprises, OEMs, and Service Providers, both on-premises and in the cloud, today announced the acquisition of all key assets of the Converged Communication Division from Dialogic Corporation.

Click here to continue reading the article

Archive